Sector-wise IPOs
Pharma & Healthcare IPOs
Mainboard and SME issues from the Pharma & Healthcare sector, and how they performed on listing.
- IPOs
- 25
- 12 Mainboard · 13 SME
- Total issue size
- ₹18,254 Cr
- 25 listed so far
- Avg. listing gain
- +18.2%
- 72% opened above issue price
| Company | Listing date | Issue size | Issue price | State | Subscribed | Listing gain | Current gain |
|---|---|---|---|---|---|---|---|
 Himalaya Nutravedics India BSE SME | 29 Sep 2026 | ₹26.5 Cr | ₹106 | Telangana | 2.24x | +11.32% | +15.66% |
 Symbiotec Pharmalab Mainboard | 1 Sep 2026 | ₹1,757 Cr | ₹988 | Madhya Pradesh | 71.26x | 0.00% | +21.26% |
 ABH Healthcare NSE SME | 1 Sep 2026 | ₹34.98 Cr | ₹102 | Punjab | 1.42x | -2.94% | -59.36% |
 Credent Connect N Care NSE SME | 20 Aug 2026 | ₹93.9 Cr | ₹189 | Delhi | 142.38x | +90.00% | +102.17% |
 Pramodini Medicare NSE SME | 19 Aug 2026 | ₹69.04 Cr | ₹118 | Andhra Pradesh | 3.66x | +1.69% | -2.50% |
 Molbio Diagnostics Mainboard | 17 Aug 2026 | ₹939.7 Cr | ₹807 | Goa | 70.26x | +21.44% | +87.50% |
 Manipal Health Enterprises Mainboard | 5 Aug 2026 | ₹9,275.22 Cr | ₹590 | Karnataka | 4.92x | +10.51% | +17.97% |
 Avience Biomedicals NSE SME | 25 Jun 2026 | ₹30.24 Cr | ₹208 | Delhi | 385.4x | +90.00% | +55.65% |
 Hexagon Nutrition Mainboard | 12 Jun 2026 | ₹138.87 Cr | ₹45 | Maharashtra | 53.68x | +7.22% | +56.42% |
 Bio Medica Laboratories NSE SME | 29 May 2026 | ₹52 Cr | ₹139 | Madhya Pradesh | 2.31x | -20.00% | +14.75% |
 Q-Line Biotech NSE SME | 29 May 2026 | ₹251 Cr | ₹343 | — | 102.49x | +31.78% | +92.74% |
 Goldline Pharmaceutical BSE SME | 19 May 2026 | ₹12 Cr | ₹43 | Maharashtra | 781.85x | +38.95% | -27.98% |
 Sai Parenteral's Mainboard | 2 Apr 2026 | ₹409 Cr | ₹392 | Telangana | 1.08x | +2.04% | +33.58% |
 Speciality Medicines BSE SME | 30 Mar 2026 | ₹29 Cr | ₹124 | Gujarat | 2.19x | 0.00% | — |
 Gaudium IVF Mainboard | 27 Feb 2026 | ₹165 Cr | ₹79 | Delhi | 7.27x | +5.06% | +38.92% |
 Accretion Nutraveda BSE SME | 4 Feb 2026 | — | ₹129 | Gujarat | 1.77x | +48.06% | +136.43% |
 Hannah Joseph Hospital BSE SME | 1 Feb 2026 | — | ₹70 | Tamil Nadu | 1.51x | -7.14% | +45.43% |
 KRM Ayurveda NSE SME | 27 Jan 2026 | — | ₹135 | Delhi | 74.43x | +27.48% | +110.67% |
| 7 Jan 2026 | — | ₹90 | Delhi | 350.49x | 0.00% | -20.11% | |
 Gujarat Kidney & Super Speciality Mainboard | 30 Dec 2025 | ₹250.8 Cr | ₹114 | Gujarat | 5.21x | +5.26% | +70.41% |
 Park Medi World Mainboard | 17 Dec 2025 | ₹920 Cr | ₹162 | Telangana | 8.1x | -1.98% | +67.16% |
 Nephrocare Health Services Mainboard | 17 Dec 2025 | ₹871.05 Cr | ₹460 | Telangana | 13.96x | +6.52% | +41.08% |
 Corona Remedies Mainboard | 15 Dec 2025 | ₹655.37 Cr | ₹1,062 | Maharashtra | 137.04x | +38.42% | +91.09% |
 Sudeep Pharma Mainboard | 28 Nov 2025 | ₹895 Cr | ₹593 | Gujarat | 93.72x | +23.10% | +102.39% |
 Rubicon Research Mainboard | 16 Oct 2025 | ₹1,378 Cr | ₹485 | Maharashtra | — | +27.84% | +236.95% |
Industry is assigned by Be IPO Ready from each company's business description and is indicative.
For business owners
In the Pharma & Healthcare business? See what your IPO could look like
Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.
- Eligibility check against NSE Emerge, BSE SME and Main Board norms
- Indicative valuation and issue size for your business
- A clear timeline from readiness to listing day
Check if your business can list
Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.
Prefer to talk? Call +91 95377 67203